Sign up for Table of Contents Alerts.
Email this page
Print this page
Commentary
DMC: Novel Celecoxib Derivatives to Rap Cancer
Paul Dent, Adly Yacoub and Steven Grant
volume 4 | issue 5
may 2005Pages: 583-584
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Commentary to:
Dimethyl-Celecoxib (DMC), a Derivative of Celecoxib that Lacks Cyclooxygenase-2-Inhibitory Function, Potently Mimics the Anti-Tumor Effects of Celecoxib on Burkitt’s Lymphoma In Vitro and In Vivo
Adel Kardosh, Weijun Wang, Jasim Uddin, Nicos A. Petasis, Florence M. Hofman, Thomas C. Chen and Axel H. Schönthal
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.